MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
2.610
-0.220 (-7.77%)
At close: Mar 6, 2026, 4:00 PM EST
2.660
+0.050 (1.92%)
After-hours: Mar 6, 2026, 7:57 PM EST

MannKind Revenue

In the year 2025, MannKind had annual revenue of $348.97M with 22.23% growth. MannKind had revenue of $111.96M in the quarter ending December 31, 2025, with 45.82% growth.

Revenue (ttm)
$348.97M
Revenue Growth
+22.23%
P/S Ratio
2.30
Revenue / Employee
$589,470
Employees
592
Market Cap
804.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025348.97M63.46M22.23%
Dec 31, 2024285.50M86.54M43.50%
Dec 31, 2023198.96M99.19M99.42%
Dec 31, 202299.77M24.33M32.25%
Dec 31, 202175.44M10.30M15.81%
Dec 31, 202065.14M2.11M3.34%
Dec 31, 201963.04M35.18M126.28%
Dec 31, 201827.86M16.11M137.20%
Dec 31, 201711.75M-163.01M-93.28%
Dec 31, 2016174.76M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xencor125.58M
CytomX Therapeutics113.63M
Kura Oncology67.48M
Evommune13.00M
KalVista Pharmaceuticals1.43M
Revenue Rankings